Identification of the transcription factor MAZ as a regulator of erythropoiesis

Darya Deen, Falk Butter, Deborah E. Daniels, Ivan Ferrer-Vicens, Daniel C.J. Ferguson, Michelle L. Holland, Vasiliki Samara, Jacqueline A. Sloane-Stanley, Helena Ayyub, Matthias Mann, Jan Frayne, David Garrick*, Douglas Vernimmen

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)


Erythropoiesis requires a combination of ubiquitous and tissue-specific transcription factors (TFs). Here, through DNA affinity purification followed by mass spectrometry, we have identified the widely expressed protein MAZ (Myc-associated zinc finger) as a TF that binds to the promoter of the erythroid-specific human a-globin gene. Genome-wide mapping in primary human erythroid cells revealed that MAZ also occupies active promoters as well as GATA1-bound enhancer elements of key erythroid genes. Consistent with an important role during erythropoiesis, knockdown of MAZ reduces a-globin expression in K562 cells and impairs differentiation in primary human erythroid cells. Genetic variants in the MAZ locus are associated with changes in clinically important human erythroid traits. Taken together, these findings reveal the zinc-finger TF MAZ to be a previously unrecognized regulator of the erythroid differentiation program.

Original languageEnglish
Pages (from-to)3002-3015
Number of pages14
JournalBlood Advances
Issue number15
Publication statusPublished - 10 Aug 2021


Dive into the research topics of 'Identification of the transcription factor MAZ as a regulator of erythropoiesis'. Together they form a unique fingerprint.

Cite this